Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Final dividend Royal DSM


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-05-03 18:21:02 -

The DSM Annual General Meeting of Shareholders on 3 May 2013 passed a resolution
to declare a dividend for 2012 of €1.50 per ordinary share of €1.50 par value.
An interim dividend of €0.48 per ordinary share having been paid on 30 August
2012, the final dividend for 2012 will amount to €1.02 per ordinary share. With
the passing of the resolution by the AGM, and in line with DSM's policy to
provide a stable and preferably rising dividend, 2012 marks the third
consecutive year DSM's dividend has been increased.

This final dividend of €1.02 will be paid out in cash or in the form of ordinary
shares at the option of the shareholder. Dividend in cash will be paid after
deduction of 15% Dutch dividend withholding tax. The 
ex-dividend date on NYSE Euronext will be 7 May 2013 and the record date will be 9 May 2013. Shareholders have from 10 May until 24 May 2013 (3.00 pm CET) to indicate their choice. On 27 May 2013 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined. This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on  20 May 2013 up to and including 24 May 2013. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2013 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext. The following timetable applies: 7 May 2013:                                                     Ex-dividend quotation 9 May 2013:                                        Record Date 10 May 2013 - 24 May 2013(3.00 pm CET):         Period in which shareholders can indicate their choice 27 May 2013 (COB):                                          Announcement of the exchange ratio 29 May 2013:                                                   Delivery of shares or cash payment DSM - Bright Science. Brighter Living.(TM) Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com. Or find us on: For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Dave Huizing tel. +31 (0) 45 5782017     tel. +31 (0) 45 5782864 e-mail media.relations@dsm.com e-mail investor.relations@dsm.com Press release-pdf: hugin.info/130663/R/1699045/560335.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: DSM N.V. via Thomson Reuters ONE [HUG#1699045]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com